- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Myeloma Progression in United Kingdom
Total 7117 results
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMultiple Myeloma in RelapseUnited States
-
University of Maryland, BaltimoreActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
University of PittsburghNovartisWithdrawnMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Oxford University Hospitals NHS TrustUniversity of Warwick; University of Birmingham; Janssen-Cilag Ltd.; BloodwiseCompletedMultiple Myeloma | Chronic Kidney DiseaseUnited Kingdom
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Japan, Bulgaria, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, Slo... and more
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnMyelodysplastic Syndromes | Progressive DiseaseUnited States
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
OncotherapeuticsKaryopharm Therapeutics IncRecruitingRefractory Multiple MyelomaUnited States
-
OncotherapeuticsTakedaTerminatedNewly Diagnosed Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Plasma Cell MyelomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedRefractory Multiple MyelomaUnited States
-
University of ArkansasCompletedMULTIPLE MYELOMAUnited States
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonRecruiting
-
University of IowaCompleted
-
LifeTime PharmaceuticalsUnknownMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
Royal Marsden NHS Foundation TrustTC BiopharmUnknown
-
University College, LondonCompletedAlzheimer Disease | Frontotemporal Dementia | Primary Progressive AphasiaUnited Kingdom
-
Pack HealthM.D. Anderson Cancer Center; Sanofi; University of WashingtonRecruitingMultiple Myeloma | Refractory Multiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States, Italy
-
Great Ormond Street Hospital for Children NHS Foundation...Wellcome TrustRecruitingRelapsed Acute Myeloid LeukaemiaUnited Kingdom
-
Travera IncMassachusetts General Hospital; Dana-Farber Cancer Institute; Weill Medical College... and other collaboratorsRecruitingMultiple Myeloma in RelapseUnited States
-
MiNK TherapeuticsCompletedRelapsed/Refractory Multiple MyelomaUnited States
-
Adriana RossiNot yet recruitingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
NYU Langone HealthCelgene CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
University of ExeterNorth Bristol NHS Trust; Royal Devon and Exeter NHS Foundation Trust; Royal United...Enrolling by invitationInterstitial Lung DiseaseUnited Kingdom
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Leeds Cancer Centre at St. James's University HospitalUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
PfizerCompletedAdvanced Multiple MyelomaGermany, United States, Spain, United Kingdom, Belgium, Canada, France, Greece
-
Celyad Oncology SANational Heart, Lung, and Blood Institute (NHLBI); Dana-Farber Cancer InstituteCompletedAcute Myeloid Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited States
-
Bristol-Myers SquibbAbbVieCompletedSmoldering Multiple MyelomaUnited States
-
Rapa Therapeutics LLCMedical College of WisconsinRecruitingRelapsed, Refractory Multiple MyelomaUnited States
-
Larysa SanchezJanssen, LPRecruitingNewly Diagnosed Multiple MyelomaUnited States
-
Case Comprehensive Cancer CenterCompletedRefractory Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNo longer availableMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Attaya SuvannasankhaNational Cancer Institute (NCI)TerminatedRefractory Multiple MyelomaUnited States
-
SanofiRecruitingRelapsed/Refractory Multiple Myeloma | Amyloid Light-chain AmyloidosisItaly, Australia, Hungary, United Kingdom, Czechia, Belgium, Spain
-
Kathleen DorritieBristol-Myers SquibbRecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Celyad Oncology SAActive, not recruitingRelapse/Refractory Multiple MyelomaBelgium, United States
-
University of LeicesterZimmer Biomet; British Heart Foundation; National Health Service, United KingdomWithdrawnSepsis | Inflammation | Organ Failure, MultipleUnited Kingdom
-
Oxford University Hospitals NHS TrustGleamerRecruitingFractures, Closed | Fracture | Fractures, Open | Bone Fracture | Dislocation | Fracture MultipleUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905 | Multiple DoseUnited Kingdom
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
University College London HospitalsUnknownProgression of Prostate CancerUnited Kingdom
-
Altor BioScienceNational Cancer Institute (NCI)TerminatedRelapsed or Refractory Multiple MyelomaUnited States